Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $25,037 |
Sells | 34 | $14,264,018 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Jun 2024 09:26 | SNDX | Syndax Pharmaceuticals Inc | GOLDAN KEITH A. | Chief Financial Officer | 14 Jun 2024 | Purchase | 1,250 | 20.0298 | 25,037 | D |
10 Aug 2023 06:50 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 09 Aug 2023 | Sale | 52,855 | 18.2651 | 965,402 | D |
03 Aug 2023 09:12 | SNDX | Syndax Pharmaceuticals Inc | MEURY WILLIAM | Director | 02 Aug 2023 | Sale | 24,000 | 20.4547 | 490,913 | D |
03 Aug 2023 09:12 | SNDX | Syndax Pharmaceuticals Inc | MEURY WILLIAM | Director | 02 Aug 2023 | Sale | 24,000 | 20.4563 | 490,951 | D |
03 Aug 2023 09:12 | SNDX | Syndax Pharmaceuticals Inc | MEURY WILLIAM | Director | 02 Aug 2023 | Sale | 35,000 | 20.4556 | 715,946 | D |
11 Jul 2023 09:23 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 10 Jul 2023 | Sale | 52,855 | 20.3967 | 1,078,068 | D |
14 Jun 2023 16:20 | SNDX | Syndax Pharmaceuticals Inc | GOLDAN KEITH A. | Chief Financial Officer | 13 Jun 2023 | Sale | 577 | 22.31 | 12,873 | D |
09 Jun 2023 17:32 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 09 Jun 2023 | Sale | 28,273 | 21.1791 | 598,797 | D |
09 Jun 2023 17:32 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 09 Jun 2023 | Sale | 24,582 | 21.1791 | 520,625 | D |
10 May 2023 16:11 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 09 May 2023 | Sale | 52,855 | 21.4072 | 1,131,478 | D |
12 Apr 2023 16:03 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | Director | 10 Apr 2023 | Sale | 52,855 | 19.5296 | 1,032,237 | D |
14 Mar 2023 16:42 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | President, Head of R&D | 13 Mar 2023 | Sale | 52,854 | 22.5276 | 1,190,674 | D |
17 Feb 2023 18:09 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 15 Feb 2023 | Sale | 17,428 | 25.8437 | 450,404 | D |
17 Feb 2023 18:09 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 15 Feb 2023 | Sale | 7,572 | 25.8437 | 195,688 | D |
08 Feb 2023 16:49 | SNDX | Syndax Pharmaceuticals Inc | METZGER MICHAEL A | Chief Executive Officer | 06 Feb 2023 | Sale | 5,959 | 27.6384 | 164,697 | D |
08 Feb 2023 16:49 | SNDX | Syndax Pharmaceuticals Inc | MORRISON BRIGGS | President, Head of R&D | 06 Feb 2023 | Sale | 52,854 | 26.8269 | 1,417,909 | D |
03 Feb 2023 16:59 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 01 Feb 2023 | Sale | 69 | 28.4281 | 1,962 | D |
13 Jan 2023 16:44 | SNDX | Syndax Pharmaceuticals Inc | LEGAULT PIERRE | Director | 13 Jan 2023 | Sale | 5,000 | 27 | 135,000 | D |
13 Jan 2023 16:44 | SNDX | Syndax Pharmaceuticals Inc | LEGAULT PIERRE | Director | 13 Jan 2023 | Sale | 10,000 | 27 | 270,000 | D |
13 Jan 2023 16:44 | SNDX | Syndax Pharmaceuticals Inc | LEGAULT PIERRE | Director | 12 Jan 2023 | Sale | 24,000 | 26.7409 | 641,782 | D |
02 Dec 2022 17:01 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 02 Dec 2022 | Sale | 17,200 | 25.0544 | 430,936 | D |
02 Dec 2022 17:01 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 01 Dec 2022 | Sale | 4,028 | 25.0114 | 100,746 | D |
02 Dec 2022 17:01 | SNDX | Syndax Pharmaceuticals Inc | ORDENTLICH PETER | Chief Scientific Officer | 01 Dec 2022 | Sale | 3,772 | 25.0114 | 94,343 | D |
07 Oct 2022 16:05 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 06 Oct 2022 | Sale | 9,117 | 25.9009 | 236,139 | D |
07 Oct 2022 16:05 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 06 Oct 2022 | Sale | 20,782 | 25.9009 | 538,273 | D |
07 Oct 2022 16:05 | SNDX | Syndax Pharmaceuticals Inc | METZGER MICHAEL A | Chief Executive Officer | 06 Oct 2022 | Sale | 16,231 | 25.2916 | 410,508 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | METZGER MICHAEL A | Chief Executive Officer | 04 Oct 2022 | Sale | 1,280 | 25.0206 | 32,026 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | METZGER MICHAEL A | Chief Executive Officer | 03 Oct 2022 | Sale | 2,883 | 25.011 | 72,107 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | METZGER MICHAEL A | Chief Executive Officer | 30 Sep 2022 | Sale | 29,606 | 25.0205 | 740,757 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 04 Oct 2022 | Sale | 223 | 25 | 5,575 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 04 Oct 2022 | Sale | 137 | 25 | 3,425 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 03 Oct 2022 | Sale | 13 | 25 | 325 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 03 Oct 2022 | Sale | 167 | 25 | 4,175 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 30 Sep 2022 | Sale | 647 | 25.0707 | 16,221 | D |
04 Oct 2022 17:49 | SNDX | Syndax Pharmaceuticals Inc | KATKIN KEITH | Director | 30 Sep 2022 | Sale | 2,914 | 25.0707 | 73,056 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)